XP analyst estimates

XP (XP) analyst ratings, the average price target and its range, and every firm's latest call.

XP analyst ratings and price targets

DateFirmCallTarget
Oct 29, 2026Morgan StanleyMorgan Stanley Downgrades XP Inc. (XP) to Equalweight$19.00
Oct 29, 2026Morgan StanleyXP Inc. downgraded to Equal Weight from Overweight at Morgan Stanley$23.00
Oct 29, 2026Banco SantanderXP Inc. downgraded to Neutral from Outperform at Grupo Santander$19.00
Oct 8, 2026UBSXP Inc. price target raised to $37 from $25 at UBS$37.00
Jan 19, 2026JefferiesXP Inc. initiated with a Buy at Jefferies$22.00
Dec 16, 2025UBSXP Inc. price target raised to $25 from $23 at UBS$25.00
Oct 16, 2025UBSXP Inc. price target lowered to $23 from $24 at UBS$23.00
Jul 11, 2024UBSXP Inc. downgraded to Neutral from Buy at UBS$21.00
Jul 2, 2024BradescoXP Inc. assumed with Neutral from Outperform at Bradesco BBI$19.00
Apr 30, 2024Goldman SachsGoldman Sachs Downgrades XP Inc. (XP) to Neutral, 'Waiting for (much) lower rates'$23.00
Apr 22, 2024Morgan StanleyXP Inc. downgraded to Equal Weight from Overweight at Morgan Stanley$24.00
Jan 24, 2024BradescoBradesco BBI Upgrades XP Inc. (XP) to Outperform$32.00
Jul 20, 2023Credit SuisseCredit Suisse Upgrades XP Inc. (XP) to Neutral$26.00
Jun 10, 2022HSBCXP (XP) Stock Price: $33 Target And Buy Rating$33.00

Updated 2026-11-02 17:50 UTC